Protalix BioTherapeutics, Inc. Annual Operating Margin in % from 2010 to 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Protalix BioTherapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2010 to 2024.
  • Protalix BioTherapeutics, Inc. Operating Margin for the quarter ending December 31, 2024 was 7.34 %, a 54.1% decline year-over-year.
  • Protalix BioTherapeutics, Inc. annual Operating Margin for 2024 was 7.34 %, a 54.1% decline from 2023.
  • Protalix BioTherapeutics, Inc. annual Operating Margin for 2023 was 16 %.
  • Protalix BioTherapeutics, Inc. annual Operating Margin for 2022 was -27.3 %, a 48.8% increase from 2021.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 7.34 -8.64 -54.1% Jan 1, 2024 Dec 31, 2024
2023 16 +43.3 Jan 1, 2023 Dec 31, 2023
2022 -27.3 +26 +48.8% Jan 1, 2022 Dec 31, 2022
2021 -53.4 -57.7 -1338% Jan 1, 2021 Dec 31, 2021
2020 4.31 +23.9 Jan 1, 2020 Dec 31, 2020
2019 -19.6 +36.8 +65.3% Jan 1, 2019 Dec 31, 2019
2018 -56.4 +107 +65.6% Jan 1, 2018 Dec 31, 2018
2017 -164 +197 +54.6% Jan 1, 2017 Dec 31, 2017
2016 -361 +182 +33.5% Jan 1, 2016 Dec 31, 2016
2015 -542 +268 +33.1% Jan 1, 2015 Dec 31, 2015
2014 -811 Jan 1, 2014 Dec 31, 2014
2012 -34.9 +401 +92% Jan 1, 2012 Dec 31, 2012
2011 -436 +15.5 +3.44% Jan 1, 2011 Dec 31, 2011
2010 -451 Jan 1, 2010 Dec 31, 2010
* An asterisk sign (*) next to the value indicates that the value is likely invalid.